Biotron Chat Room
by | April 7, 2014 9:31 am
This discussion is designed to run parallel with the Dr KSS’s article ’Another Hot Australian Biotech: Is Biotron Right for Your Portfolio?’ http://www.stockgumshoe.com/2014/04/microblog-another-hot-australian-biotech-is-biotron-right-for-your-portfolio/[1] and serves to provide a free general chat room. With luck it will stop the main thread becoming so cluttered with (while often v interesting), random/off topic/thank you posts. If the strategy doesn’t work/appeal, it can easily be ignored/ditched without affecting the main thread. GLA
AlanH
Endnotes:
- http://www.stockgumshoe.com/2014/04/microblog-another-hot-australian-biotech-is-biotron-right-for-your-portfolio/: http://www.stockgumshoe.com/2014/04/microblog-another-hot-australian-biotech-is-biotron-right-for-your-portfolio/
Source URL: https://www.stockgumshoe.com/2014/04/microblog-biotron-chat-room/
Kenny, I want to take advantage of the prices as well – can’t decide where to take advantage. I don’t have a position in QRXPY or DRTX. I do have BNIKF, ISR,CTIX,PTN,SNWV,ATHJF and OXBT. Can’t decide to reduce my cost basis in OXBT (5.65!) or take new positions in QRXPY and DRTX.
Is anyone else in buy mode, or waiting to see how the next couple sessions play out?
Great post Pockets! I am happy there is another solution for those who don’t use Outlook.
Hey Bradley: I am holding OXBT, ATHJF, QRXPY, DRTX, CTIX, PTN, SNWV, BNIKF,ELTP,AND ISR
I took my profits in ISR and then went back in for small position when it came back, QRXPY is back where I entered so I am good there, I am waiting for DRTX to find its bottom to average down, as I bought at $14.00, I will take additional purchases in CTIX, BNIKF, and maybe SNWV.
Also looking for possibly another 5k in ATHJF if I am confortable enough with the bottom end.
Also holding Mankind as I wan’t smart enough to sell when it hit $8.00 (Oh Well) I will hang on to it and see where it goes. I think it has room to grow some more.
Thanks Thomas, I have an order in for 1K QRXPY at 3.87 – it hasn’t filled yet. I wish I would have been in Mannkind! I got in ISR near close yesterday and paid 1.67 – it is the only green in my portfolio today.
Bummer Bradley: I am looking at the last sale on Level II at 15:54:34 EDT for $3.86 2500K
Funny the one I care about the least is ISR but I have been watching it for a year got in and out when it would ride up from $.55 to $.89 and back and forth. I did that several times, and then was able to get in at $.80 and bought more at $.99 and rode it up for my biggest gain ever. Sold enough to cover cost and then the balance at $2.80 Now I am back in at the same price because I think something is going to break with them as far a buy out. I just have a small position now though couple hundred shares. PTN is back where I bought it now at $1.29 which I like.
Bradley – I am holding the same positions as you plus couple others but no SNWV. May buy that one soon. Showing profits in PTN, PVCT (which I have been looking to sell but doing good), QRXPY and slight profit in ECTE. I had been averaging down on RNN and CTIX and DRTX but prices down since, so should have waited (thats the 20/20 hindsight thing). Had a 1 day buy/sell of ISR for nice profit, and haven’t gone back in and dont intend to. Otherwise I am holding pat for now but if Beni should further weaken I plan on getting more although it is already my biggest security holding. Call that faith in DR. KSS!
….. and after just reading KSS’s latest post re ECTE I may consider selling that next week. Ain’t this fun?!
GILD, Pricing and politics…
Some thoughts on the pricing of GILD’s Sovaldi, the political reaction, and what we might expect in the future.
As Dr KSS said, it is cheaper to for the country to treat HCV patients with Sovaldi than to endure the costs of treating them over the long term. However, as a taxpayer, I have sympathy with the congressional questions over the cost per patient. This is not a simple question to deal with as there are many factors and many players in the game. So here are some thoughts I’ve had on what may be motivating the various players and how it might all come out.
1. GILD sees ABBV and others coming out with potential cures for HPV, so their primary interest is to get as much $$ up front for its first to market solution as it can. Other players will undercut their pricing later, including Benitec.
2. Congressfolk see that if we treat all HCV patients with Sovaldi as fast as possible, it can hurt the USA eonomically. While Dr KSS explains that it is cheaper to use Sovaldi at proposed pricing than to pay the lingering healthcare costs of HCV sufferers, he has also said that most hepatitis victims have made poor life choices in the past. I think congress should question whether the savings in future health care costs of Sovaldi will ever happen. As soon as these patients get healthy, they could make other poor choices and we’ll be faced with continuing healthcare costs for these people anyway for other diseases. My interest, as a taxpayer (and also as a BNKIF investor) is to slow down the spending on Sovaldi, let other solutions come to market, and monitor what actually happens with a few patients that actually are treated with Sovaldi.
3. ABBV, Merck and others who want to sell hepatitis cures have responsibilities to their shareholders & bosses to make a return on their considerable investments. Fast rollout of GILD and Sovaldi are an obstacle to that. Thus ABBV, Merck etc can slow down GILD’s progress by hiring lobbyists to gum up the works. While it feels good to diss dumb congressfolk, my take is that their concern is spurred by expensive lobbying efforts funded by smart capitalists, not dumb liberals. Healthcare insurers also have an interest here: Are they humanists who want to cure HCV ASAP? Or capitalists who would rather wait until competition drives down prices? I’d bet on the latter.
4. So what’s the implication for Benitec, GILD & others? I think that congressional concern is a positive for Benitec — it would not be a good investment if GILD cures all the patients in the next 2 years while Beni brings their cure to market. As a taxpayer and an investor in BNIKF (and a big fan of enlightened self interest), I think that congress really should take a look at the market and see if we can get a more cost effective, market based cure out there. Whether that happens via GILD cutting prices, or slow-rolling their rollout, or whatever, I’m not gonna write congress and protest. Thus I think GILD will make some good loot on Sovaldi, but I don’t think their pricing power will last very long, so I’m not buying GILD. I will hold BNIKF as they own not just the market mechanism for making HCV & HCB cures more cost effective, but also key technologies that can be applied to several other diseases.
I’d be interested in the thoughts of others on this topic.
timmuggs; I think you have a good read as to how things actually work & I do not blame Congress or the President for that.. I blame the voters for not doing their homework.
Personally I am glad we don’t get all the government we pay for. fa
Where is it written in our Constitution that Congress or the Executive Branch are responsible for health care management and empowered to act in “regulating” health care ? The only legitimate regulatory role of the federal government in this arena is that served by the FDA (i.e., public safety). If Congress and the Executive Branch adhered to the “First Do No Harm” principle, they would abstain from illegitimate (i.e., without Constitutional empowerment) meddling in health care.
Frank, it would be nice if we got SOME of the government that we pay for.
timmuggs — post 47 —
Great post, well reasoned, and very informative. But I doubt that our amazingly do-little congress will address the topic. They are focused only on the 2016 election.
Hmmmmmm…do-little…..Maybe we need a Dr. Dolittle to talk to the animals there.
Hey om sharma, I’d love to hear your thoughts on Sigma Labs (SGLB) when you get a chance to share your expertise. I have been in the stock with a small amount of money since last summer also.
Elliot Sedlecky –
In 3D printing arena SGLB have good reputation.
They have solid key patents.
High-level scientists and engineers out of Los Alamos National Laboratory with great attitude and very hard working. They spend less mount of $$ with outside services and do most of the experimental stuff in the house.
Working with GE and Honeywell like big companies, sigma-labs is providing advanced manufacturing expertise in the area of systems integration technology and support for these companies.
Sigma-labs developed in-process inspection technology known as PrintRite3D® that allows manufacturers of safety-critical components to inspect the product as it’s being made instead of after the fact. By inspecting the product in-process opposed to post-process customers dramatically reduce their overall inspection costs by only inspecting product identified as a suspect during the manufacturing process. Quality in-process and on-machine is key as components are expensive and complex in aircraft.
They have “Real Time Nondestructive Inspection” tool/software which is helping companies in many areas of manufacturing reduce costs and improve quality with their QualitySentinel technology.
Build the next generation of lighter, greener, and more fuel efficient aircraft through novel additive manufacturing technology. GE is using SGLB technology and devices with ARCAM technology in process of Electron beam melting.
Advanced Recovery and Integrated Extraction System and is the only program in the nation that disassembles and destroys surplus plutonium pits. The pits are transformed into plutonium oxide powder suitable for being made into fuel for civilian nuclear reactors
Now they are on the way to bring LOW-COST 3D METAL PRINTER.
This was the first penny stock I took seriously among 3D printing companies.
Last year SGLB went up to 500% up and down around 300% Still a lot up compares to bigger companies like DDD and others.
I got in when it was .18/stock. I see big growth ahead as 3d printing market has not started yet very well still very premature stage.
I am long – SGLB, BNKIF, RNN
Has your opinion changed on Sigma Labs? I just came across this article http://www.nanalyze.com/2014/08/will-sigma-labs-finally-deliver-on-their-promises/ Please tell me what you think.
Logging in again. Seems not to help.
Leo, You have to check the box that says “notify me…”
Elliot, I’m in the West Bloomfield area, where are you?
I’m in Grand Rapids!
Ive been to GR a few times, it’s about 2.5 hour drive. I’ve been in my area for 55 years. The winter used to be a lot of fun for me as I participated in winter sports. Now that i’m older, not so much. I have the means to move to a warmer climate, but I think i’m going to be a lifer – I do enjoy the seasons.
I’m only 26, Bradley, but I’ve lived here all my life and don’t foresee a move. Cheers
Log
Thanks Elliot
Thanks very much for sharing this with us.